**Author details**

Mehmet Semih Demirtaş Department of Pediatrics, Aksaray University Education and Research Hospital, Aksaray, Turkey

\*Address all correspondence to: md.semihdemirtas@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**33**

*The Pathogenesis of Congenital Anomalies: Roles of Teratogens and Infections*

[9] Alexander PG, Clark KL, Tuan RS. Prenatal exposure to environmental factors and congenital limb defects. Birth Defects Research. Part C, Embryo Today. 2016;**108**(3):243-273. DOI:

[10] Calado AM, Dos Anjos Pires M. An overview of teratology. Methods in Molecular Biology. 2018;**1797**:3-32

[11] Brent RL. Environmental causes of human congenital malformations: The pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics.

[12] Jones KL, Jones MC, del Campo Casanelles. Fetal hydantoin syndrome (fetal dilantin syndrome). In: Smith's Recognizable Patterns of Human Malformation. 7th ed. Philadelphia, PA:

Elsevier Saunders; 2013. p. 734

10.3843/GLOWM.10096

[14] Van Rooij IA, Miller RK,

10.1093/humupd/dmp052

[15] Thorpe PG, Gilboa SM,

Safety. 2013;**22**:1013-1018

associated with teratogenic

[13] Niebyl J, Simpson J. Teratology and drugs in pregnancy. In: Global Library of Women's Medicine; 2008. DOI:

Zielhuis GA, de Jong-van den Berg LT, Roeleveld N. Teratogenic mechanisms of medical drugs. Human Reproduction Update. 2010;**16**(4):378-394. DOI:

Hernandez-Diaz S, Lind J, Cragan JD, Briggs G, et al. Medications in the first trimester of pregnancy: Most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiology and Drug

[16] Van Gelder MMHJ, de Jong-van den Berg LTW, Roeleveld N. Drugs

mechanisms. Part II: A literature review

10.1002/bdrc.21140

2004;**113**:957-968

*DOI: http://dx.doi.org/10.5772/intechopen.92580*

[1] Hennekam RC, Biesecker LG, Allanson JE, Hall JG, Opitz JM, Temple IK, et al. Elements of morphology: General terms for congenital anomalies. American Journal of Medical Genetics: Part A.

2013;**161A**:2726-2733

1962;**7**:253-258

**References**

bdra.23231

[2] Lenz W, Knapp K. Foetal malformations due to thalidomide.

German Medical Monthly.

[4] Maitra A. Genetic and pediatric diseases. In: Kumar V, Abbas AK, Aster JC, editors. Robbins Basic Pathology. 9th ed. Philadelphia:

Elsevier; 2013. pp. 243-298

[5] Moore KL, Persaud TVN,

Organization; 2014

Torche MG. The Developing Human: Clinically Oriented Embryology. 10th ed. Philadelphia: Elsevier; 2015

[6] WHO/CDC/ICBDSR. Birth Defects Surveillance: A Manual for Programme Managers. Geneva: World Health

[7] Finnell R. Teratology: General considerations and principles. The Journal of Allergy and Clinical

10.1016/S0091-6749(99)70259-9

[8] Cassina M, Cagnoli GA, Zuccarello D, Di Gianantonio E, Clementi M. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. European Journal of Medical Genetics. 2017;**60**(1):22-31. DOI: 10.1016/j.ejmg.2016.09.011

Immunology. 1999;**103**:S337-S342. DOI:

[3] Luteijn JM, Dolk H, Addor MC, Arriola L, Barisic I, Bianchi F, et al. Seasonality of congenital anomalies in Europe. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2014 Apr;**100**(4):260-269. DOI: 10.1002/

*The Pathogenesis of Congenital Anomalies: Roles of Teratogens and Infections DOI: http://dx.doi.org/10.5772/intechopen.92580*
